United States Pharmacopeial Convention
The United States Pharmacopeial Convention (USP) is a public charity based in Rockville, Maryland. It is a scientific organization that develops standards and science-based solutions intended to help increase the supply of quality medicines, dietary supplements, and food ingredients.
United States Pharmacopeial Convention at a glance
In short: United States Pharmacopeial Convention gave $256K across 17 grants in 2025 (avg $15K), top state District of Columbia. 41% of 2025 grantees were new. Source: 2025 IRS Form 990.
- Annual giving (2025)
- $256,437
- +1.6% vs 2024
- Grants made (2025)
- 17
- +41.7% vs 2024
- Average grant
- $15,085
- -28.3% vs 2024
- Median grant
- $10,000
- Total assets
- $788,657,741
- +5.0% vs 2024
- New grantees (estimate)
- 41% first-time grantees (7 of 17, 2025; small sample)
- Primary geography
- District of Columbia (37% of itemized 2025 grant dollars)
- Latest 990 filing
- Form 990, 2025 View filing
Data from IRS Form 990, 2025; updated September 2026. New grantees are estimated by matching recipient names across years (methodology).
How to apply to United States Pharmacopeial Convention
- How to Apply
-
The Next Generation Scientists program’s application window is closed.
- Contact
Mailing address: 12601 Twinbrook Parkway, Rockville, MD 20852
Phone: (301) 881-0666
Website: https://usp.org
Application details from Grantable's research on the foundation's public materials; confirm on its website before applying.
Who United States Pharmacopeial Convention funds
How this funder distributes its grants
Top Recipients
Top 10 recipients in 2025
The largest 2025 recipient was Association for Accessible Medicines ($33K). Together the top 10 received $197K.
Grant Size Distribution
62 grants across all recorded years
The most common grant size was under $50K: 58 grants of 62 (94%).
Geographic Focus
Where this funder awards grants
USP is based in Rockville, Maryland. In 2025, the largest shares of grant dollars went to recipients in Washington, DC (37%), Maryland (18%), and Virginia (17%), followed by New Jersey (8%) and New York (5%). These figures describe the locations of 2025 grant recipients.
Grant Distribution by State
Share of 2025 grant dollars across all 17 itemized grants.
States
Cities
Is United States Pharmacopeial Convention open to new grantees?
41%
first-time grantees, 2025
In 2025, 7 of 17 grantees (41%) were first-time recipients. With only 17 grantees, that is a small sample: one grantee more or less moves the share by about 6 points. First grants averaged $16K; repeat grants $14K. How we count
Medians: $12K first-time, $10K repeat.
Estimate from itemized grant lists in IRS Form 990 filings (2020–2025). Recipient names are matched across years, so a renamed or misspelled grantee can look new; grants to individuals are left out. Methodology.
Giving History
Giving Over Time
Total grant dollars and number of grants per year
From 2020 to 2025, annual grant giving ranged from $227K (2021) to $662K (2022). In 2025 it made 17 grants totaling $256K.
Grants by year
Grant recipients and amounts by year
| Recipient | Purpose | Amount |
|---|---|---|
| Association for Accessible Medicines Washington, DC | Sponsorship - Aam 2024 GRX+ Biosims | $32,700 |
| American Pharmacists Association Washington, DC | Apha 2025 Annual Meeting - Sponsorship | $27,737 |
| Project Hope Millwood, VA | Inaugural Charity Golf Tournament Sponsorship | $25,000 |
| Biohealth Innovation Inc Rockville, MD | Charitable Donation | $25,000 |
| Newark Mentoring Movement Newark, NJ | Newark Mentoring Movement | $20,000 |
| George Washington's Mount Vernon Mount Vernon, VA | Charitable Donation | $19,500 |
| Reagan Udall Foundation for the Food and Drug Administration Inc Washington, DC | Annual Innovations in Regulatory Science Awards - Sponsorship | $15,000 |
| Worldwide Business Research USA LLC New York, NY | Logipharma US 2024 Meeting - Sponsorship | $12,000 |
| Alliance for Aging Research Washington, DC | Annual Dinner Sponsorship | $10,000 |
| Consumer Health Products Association Washington, DC | Platinum Level Sponsorship | $10,000 |
Ready to take the next step with United States Pharmacopeial Convention?
Financial History
Multi-year comparison from IRS filings
| Filing year | Total Assets | Revenue | Expenses | Grants paid | Grants | Net Investment Income |
|---|---|---|---|---|---|---|
| 2025 | $788,657,741 | $357,720,644 | $333,614,948 | $256,437 | 17 | $21,655,407 |
| 2024 | $750,835,911 | $353,749,327 | $330,337,653 | $252,498 | 12 | $10,536,524 |
| 2023 | $701,768,432 | $346,271,530 | $313,280,612 | $268,062 | 12 | $10,363,719 |
| 2022 | $655,709,010 | $342,334,376 | $290,499,670 | $661,500 | 11 | $15,642,447 |
| 2021 | $667,918,646 | $331,132,598 | $285,960,328 | $226,750 | 10 | $14,938,020 |
| 2020 | $558,856,219 | $318,679,360 | $305,692,076 | $242,900 | 5 | $4,230,707 |
Research compiled by Grantable AI from public sources. Last updated September 2026.
Mission & Focus Areas
USP’s mission, as stated in its 2024 filing, is “to improve global health through public standards and related programs that help ensure the quality, safety, and benefit of medicines and foods.” Its website describes work on standards and science-based solutions for medicines, dietary supplements, and food ingredients.
USP’s Next Generation Scientists research grants support proposals in pharmaceutical medicines, dietary supplements, and foods that connect with quality or supply-chain issues and could benefit quality assurance or help USP create standards or products. The program evaluates strategic relevance, scientific merit, and novelty. USP also describes fellowship opportunities for graduate-level research aligned with its mission and strategic goals.
Examples of 2025 grant recipients illustrate a range of supported organizations. The Association for Accessible Medicines says it promotes the interests of the generic pharmaceutical and biosimilars industry. The American Pharmacists Association describes itself as a professional organization that equips pharmacists for patient-centered care. BioHealth Innovation says it connects research assets with funding, management, and markets to support commercially viable biohealth products and companies. Newark Mentoring Movement says it connects people and organizations with mentoring programs to support Newark’s youth. The Alliance for Aging Research says it works toward healthy aging and equitable access to care.
Grantmaking
In filing year 2025, USP reported 17 grants totaling $256,437. Grants ranged from $6,000 to $32,700, with a median of $10,000. The largest listed grants included $32,700 to the Association for Accessible Medicines for sponsorship of AAM 2024 GRX+ BIOSIMS; $27,737 to the American Pharmacists Association for sponsorship of its 2025 annual meeting; and $25,000 each to Project HOPE for an inaugural charity golf tournament sponsorship and BioHealth Innovation for a charitable donation. Other listed awards included $20,000 to Newark Mentoring Movement and $15,000 to the Reagan-Udall Foundation for the FDA for sponsorship of its annual Innovations in Regulatory Science Awards.
USP’s Next Generation Scientists research grant guidelines call for budgets of $5,000 to $50,000; the number and amount of awards vary with applications received and the annual budget. Applicants must be current or recent students in an accredited master’s- or Ph.D.-granting program; applicants need not reside in the United States. Applications request a CV or résumé, anticipated challenges, budget, timeline and milestones, and a research concept aligned with USP’s mission and Science Quality Framework. Typical projects take one to two years. Recipients are assigned a USP mentor, submit annual scientific and financial reports, and present their research in a virtual lecture. The website states that the application window is closed.
USP’s filing says it sets grant-specific reporting processes and timing. At minimum, recipients are expected to provide a narrative statement on progress toward the grant’s purpose. For sponsorships, organizations provide acknowledgment of receipt and confirmation that funds were used for the agreed purpose.
Leadership & Key People
Leadership team and compensation from IRS filings
Officers and trustees listed on the 2025 filing include Dennis E. Doherty, MD, Convention President; Todd K. Abraham, PhD, MBA, Treasurer; Gregory E. Amidon, PhD, Pharmaceutical Sciences Trustee; Gwen Darien, Public Trustee; Richard J. Gilfillan, MD, MBA, At Large Trustee; Jesse L. Goodman, MD, MPH, Medical Sciences Trustee; Laura Herman, MBA, MA, At Large Trustee; Thomas Menighan, BPharm, MBA, At Large Trustee; Krishna Reddy Nallamalla, MD, At Large Trustee; and Stephen Ostroff, MD, Medical Sciences Trustee.
United States Pharmacopeial Convention is led by Ronald T. Piervincenzi, Chief Executive Officer & Ex-Officio since 2022 (on filings since 2020); 13 of 26 officers listed in 2025 are compensated.
Officers on the 2025 filing
Ronald T. Piervincenzi
Chief Executive Officer & Ex-Officio
Chief Executive Officer → Chief Executive Officer & Ex-Officio, 2022
On filings since 2020
38 hrs/week
$832K (2020) → $975K (2025)
Dennis E. Doherty MD
Convention President
President → Convention President, 2022
On filings since 2021
4 hrs/week
No compensation reported
Susan Winckler Rph JD
Chair & Pharma Sci Trustee
On filings since 2022
4 hrs/week
No compensation reported
Gregory E. Amidon PhD
Pharmaceutical Sciences Trustee
Pharmaceutical Trustee → Pharmaceutical Sciences Trustee, 2023
On filings since 2020
4 hrs/week
No compensation reported
Jesse L. Goodman MD MPH
Medical Sciences Trustee
President → Medical Sciences Trustee, 2021
On filings since 2020
4 hrs/week
No compensation reported
Laura Herman Mba Ma
At Large Trustee
Public Trustee → At Large Trustee, 2021
On filings since 2020
4 hrs/week
No compensation reported
Gwen Darien
Public Trustee
On filings since 2021
4 hrs/week
No compensation reported
John Taylor JD
At Large Trustee
On filings since 2021
4 hrs/week
No compensation reported
Krishna Reddy Nallamalla MD
At Large Trustee
On filings since 2021
4 hrs/week
No compensation reported
Richard J. Gilfillan MD MBA
At Large Trustee
On filings since 2021
4 hrs/week
No compensation reported
Stephen Ostroff MD
Medical Sciences Trustee
On filings since 2021
4 hrs/week
No compensation reported
Julio Sanchez Y. Tepoz Mscsjd
At Large Trustee
On filings since 2022
4 hrs/week
No compensation reported
Thomas Menighan Bspharmmba
At Large Trustee
On filings since 2022
4 hrs/week
No compensation reported
Amanda D. Cowley
Senior Vice President, Legal, Strategy & People
General Counsel - → Senior Vice President Legal People Strategy, 2021
Senior Vice President Legal People Strategy → Senior Vice President, Legal, Strategy & People, 2025
On filings since 2020
38 hrs/week
$355K (2020) → $531K (2025)
Anthony P. Lakavage
Secretary & Senior Vice President Glbl Ea
Secretary → Senior Vice President Glbl Ea, 2022
Senior Vice President Glbl Ea → Secretary & Senior Vice President Glbl Ea, 2023
On filings since 2020
38 hrs/week
$415K (2020) → $545K (2025)
Emily M. Kaine
Senior Vice President, Gbl Health & Manufacturing Svcs
Senior Vice President & Global Health → Senior Vice President & Ghms, 2022
Senior Vice President & Ghms → Senior Vice President, Gbl Health & Manufacturing Svcs, 2024
On filings since 2020
38 hrs/week
$367K (2020) → $527K (2025)
Jennifer Devine
Senior Vice President, Doc Stds & Comp Policy
On filings since 2020
38 hrs/week
$329K (2020) → $419K (2025)
Stanley D. Burhans
Chief Financial Officer
Chief Financial Officer → Chief Financial Officer, Senior Vice President & Ops, 2024
Chief Financial Officer, Senior Vice President & Ops → Chief Financial Officer, 2025
On filings since 2020
38 hrs/week
$410K (2020) → $508K (2025)
Bruk Alemayehu
Senior Vice President, Global Lab & Technical Ops
Senior Vice President & Glto → Senior Vice President, Global Lab & Technical Ops, 2024
On filings since 2021
38 hrs/week
$352K (2021) → $430K (2025)
Michael S. Levy
Senior Vice President, Digital & Innovation
Senior Vice President, Dig & Innov → Senior Vice President, Digital & Innovation, 2023
On filings since 2022
38 hrs/week
$360K (2022) → $442K (2025)
Fouad Atouf
Senior Vice President & Sci-Glob Bio
On filings since 2023
38 hrs/week
$350K (2023) → $424K (2025)
Venkat Surendra Nath Koduru
Senior Vice President Regions & Program Ops.
On filings since 2023
38 hrs/week
$451K (2023) → $491K (2025)
Debra J. Perez
Chief Equity Officer
On filings since 2024
38 hrs/week
$411K (2024) → $450K (2025)
Jakob Venema To
Executive Vice President & Chief Science Officer
New on the 2025 filing
38 hrs/week
$619K (2025)
John A. Giannone To
Vice President & Compendial Operations
New on the 2025 filing
38 hrs/week
$552K (2025)
Todd K. Abraham PhD MBA
Treasurer
At-Large Trustee → Treasurer, 2021
On filings since 2020
4 hrs/week
No compensation reported
Former officers (27)
- Former: Jakob Venema (2020–2024) — Executive Vice President & Chief Science Officer
- Former: Kenneth B. Alexander - Vp Dep (2024) — Gc & Vice President Mng Aty Glb Lg Aff
- Former: Nurisha R. Wade - Vp Hqs Coe (2024) — Vice President & Industry Programs
- Former: Robert L. Anderson (2022–2023) — Vice President & Mktg Comms Executive
- Former: Dawn M. Oram (2023) — Head of Gpc
- Former: Deidre E. Boulware (2022) — Vice President & Global Hr
- Former: Kenneth B. Alexander (2022) — Vice President & Deputy Gc
- Former: Hermes Van Der Lee (2020–2021) — Senior Vice President & Global Lab Ops · Filing note: Ended 920
- Former: Salah D. Kivlighn (2020–2021) — Senior Vice President & Global Smpo · Filing note: Ended 5220
- Former: Adetokunbo J. Joseph (2021) — Vice President & Global Compliance Ethics · Filing note: Ended 720
- Former: John B. Atwater (2021) — Senior Director & Verification Programs · Filing note: Ended 7220
- Former: Julio Sanchez Y. Tepoz Mscs JD (2021) — At Large Trustee
- Former: Samir Z. Wahab (2021) — Vice President & Global Rsl · Filing note: Ended 7220
- Former: Susan Winckler Bs Pharmjdfa (2021) — Chair & Pharma Sci Trustee
- Former: Thomas Menighan Bspharm MBA (2021) — At Large Trustee
- Former: Ben A Firschein (2020) — Director, Gea Rsrch & Analysis
- Former: Christine Stunyo (2020) — Senior Vice President Global Human Resources
- Former: Gail R Wilensky PhD (2020) — At-Large Trustee
- Former: John E Courtney PhD (2020) — Treasurer
- Former: Marilyn K Speedie PH (2020) — Pharmaceutical Trustee
- Former: Paul Chew MD (2020) — Medical Sciences Trustee
- Former: Robert J Meyer MD (2020) — Medical Sciences Trustee
- Former: Satyanarayana Chava P (2020) — At-Large Trustee
- Former: Scott P Henderson (2020) — Senior Vice President, Info & Svcs -
- Former: Susan S De Mars (2020) — Frmr Chf. Legal Officer -
- Former: Susan Winckler BS PHA (2020) — Chair
- Former: Timothy R FransonBS (2020) — Past President
Data from IRS Form 990 filings, 2020–2025. "On filings since" is the earliest filing we hold that lists the person; hours are average hours per week as reported.
Compensation Overview
From 2025 IRS filing
The highest reported compensation on the 2025 filing was $975K, to Ronald T Piervincenzi (Chief Executive Officer & Ex-Officio). 13 officers or directors reported compensation on that filing.
Frequently asked questions about United States Pharmacopeial Convention
How much does United States Pharmacopeial Convention give each year?
United States Pharmacopeial Convention gave $256K across 17 grants in 2025, according to its 2025 IRS Form 990. In 2024 it gave $252K across 12 grants.
What is United States Pharmacopeial Convention's typical grant size?
United States Pharmacopeial Convention's median grant in 2025 was $10,000, and its average grant was $15,085, across 17 grants on its 2025 IRS Form 990. Organizations receiving their first grant from United States Pharmacopeial Convention that year got $16K on average.
Where does United States Pharmacopeial Convention give grants?
United States Pharmacopeial Convention's top state is District of Columbia, with 37% of the grant dollars itemized on its 2025 IRS Form 990. The next largest states were Maryland (18%) and Virginia (17%). The most frequent recipient cities were Washington, DC (5 grants) and Rockville, MD (2 grants).
Does United States Pharmacopeial Convention give general operating support?
Not in 2025: none of the 17 grants with a stated purpose on United States Pharmacopeial Convention's 2025 IRS Form 990 were described as general or operating support.
Who are United States Pharmacopeial Convention's largest grantees?
United States Pharmacopeial Convention's largest 2025 grantees include Association for Accessible Medicines ($32,700), American Pharmacists Association ($27,737) and Project Hope ($25,000), according to its 2025 IRS Form 990. Together they received 33% of its itemized 2025 grant dollars.
How large is United States Pharmacopeial Convention?
United States Pharmacopeial Convention reported $788.7M in total assets on its 2025 IRS Form 990. Its revenue that year was $357.7M.
What does United States Pharmacopeial Convention fund?
USP’s mission, as stated in its 2024 filing, is “to improve global health through public standards and related programs that help ensure the quality, safety, and benefit of medicines and foods.” See mission & focus areas ↑
How do I apply for a grant from United States Pharmacopeial Convention?
The Next Generation Scientists program’s application window is closed. Eligibility and process details are in the grantmaking section of this profile. See how to apply ↑
What is United States Pharmacopeial Convention's EIN?
United States Pharmacopeial Convention's EIN (Employer Identification Number) is 13-1656692. IRS Form 990 filing data is available on this page for 2020–2025.
Data last updated September 2026. Sourced from IRS Form 990 filings. Research dossier generated September 2026.
Data update history
(7)
When this profile's IRS filing data changed on Grantable
- Updated Form 990 for fiscal year 2021 (received by the IRS November 15, 2021)
- Updated Form 990 for fiscal year 2022 (received by the IRS November 15, 2022)
- Updated Form 990 for fiscal year 2023 (received by the IRS November 13, 2023)
- Updated Form 990 for fiscal year 2024 (received by the IRS November 14, 2024)
- Updated Form 990 for fiscal year 2025 (received by the IRS November 13, 2025)
- Updated Form 990 for fiscal year 2020 (received by the IRS November 16, 2020)
- IRS filings on file for fiscal years 2020–2025
Live grants for the work United States Pharmacopeial Convention funds
Health Open opportunities, soonest deadline first.
Explore Open Grants
Browse active grant opportunities in United States Pharmacopeial Convention's focus areas in our free grants database
Similar Funders
Funders that support many of the same organizations
Consumer Healthcare Products Association
Washington, DC
CHPA supports organizations working on consumer health, self-care, health education, research, and related policy, generally through funding for specific events or programs. In 2024, its 17 grants ranged from $6,000 to $55,000, with a median of $11,000, and went to recipients in several states, especially Virginia, Washington, DC, and New York. The profile does not state whether CHPA accepts unsolicited requests.
Assets
$35.1M
Grants
17
Total Given
$312K
Aetna Foundation Inc
Hartford, CT
Aetna Foundation supported health and wellness, access to health care, and related community needs; its 2021 grants ranged from $5,000 to $1 million, with a median of $40,000, and went to organizations across multiple states, especially in D.C. and Connecticut. Its 2021 filing was marked final, so it appears to have ended or be winding down grantmaking; that filing said there were no restrictions on who could apply and pointed applicants to its website for application materials.
Assets
—
Grants
65
Total Given
$7.2M
McKesson Foundation Inc
Dallas, TX
The McKesson Foundation funds cancer support and care, healthcare workforce pathways, and emergency response, with grants mainly supporting organizations in the United States and Canada. Its 2025 grants had a median of $100,000, though amounts ranged from $10,000 to about $2.47 million. Its filing says it does not accept unsolicited requests, while its application page describes an online application process with stated submission windows.
Assets
$1.6M
Grants
76
Total Given
$16.6M
Pharmaceutical Research and Manufacturers of America
Washington, DC
PhRMA funds organizations and initiatives related to biopharmaceutical research, patient access and affordability, health care policy, and public education, with grants mainly going to U.S. recipients. Its 2024 grants had a median of $20,000, though awards ranged from $5,250 to more than $6.8 million. The profile does not state whether it accepts unsolicited requests.
Assets
$349.0M
Grants
461
Total Given
$41.4M
Bristol-Myers Squibb Foundation Inc
Princeton, NJ
The Bristol-Myers Squibb Foundation supports health access and stronger health systems, with a focus on adult and pediatric cancers, blood disorders, brain health, and clinical-trial participation in the United States, Brazil, India, and ten Sub-Saharan African countries. In 2024, its median grant was about $134,000, though awards varied widely; it does not state whether it accepts unsolicited requests, and advises prospective applicants to contact the Foundation about its process.
Assets
$83.3M
Grants
144
Total Given
$67.7M
Motorola Solutions Foundation
Chicago, IL
The Motorola Solutions Foundation funds first-responder programs and technology and engineering education, especially for under-resourced communities; its 2025 grants had a median of $35,000. It supports organizations worldwide, with priority for communities where Motorola Solutions operates, and accepts unsolicited requests through an annual letter-of-inquiry process, with full applications by invitation.
Assets
$1.2M
Grants
213
Total Given
$12.6M
More similar funders
More Funders in Maryland
Cite this profile
Grantable. (2026). United States Pharmacopeial Convention funder profile. GrantGraph. Retrieved October 25, 2026, from https://grantable.co/funders/united-states-pharmacopeial-convention-morg_c9b9b006f6b34ead940981c62a264af2
BibTeX
@misc{grantable_131656692_2026,
author = {{Grantable}},
title = {{United States Pharmacopeial Convention funder profile}},
howpublished = {GrantGraph},
year = {2026},
url = {https://grantable.co/funders/united-states-pharmacopeial-convention-morg_c9b9b006f6b34ead940981c62a264af2},
note = {Accessed 2026-10-25. Data licensed CC BY 4.0}
}The figures on this page are open data under CC BY 4.0: reuse them with credit to Grantable and a link. Download the data.
Figures come from United States Pharmacopeial Convention's IRS filings (methodology). AI-written summaries, news items and logos are not covered by the open licence. Spot an error? Email hello@grantable.co.
United States Pharmacopeial Convention down — hundreds of funders to go?